Connor, Clark & Lunn Investment Management (CC&L)
LUNG icon

Connor, Clark & Lunn Investment Management (CC&L)’s Pulmonx LUNG Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,237
Closed -$32.8K – 1681
2025
Q3 		$32.8K Sell
20,237
-198,521
-91% -$415K ﹤0.01% 1472
2025
Q2 		$567K Buy
218,758
+53,148
+32% +$210K ﹤0.01% 1215
2025
Q1 		$1.11M Buy
165,610
+81,669
+97% +$578K ﹤0.01% 916
2024
Q4 		$570K Buy
83,941
+25,988
+45% +$171K ﹤0.01% 1109
2024
Q3 		$480K Buy
+57,953
New +$419K ﹤0.01% 1107

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $10.1B AUM 30.13% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return